News
Skills and TrainingNew survey shows UK cell and gene therapy industry expects workforce to return to growth, following a challenging period of headcount reductions
Ian Murray MP visits the Cell and Gene Therapy Catapult, learning about its work supporting the advanced therapy sectorCGT Catapult and Nakanoshima Qross to foster stronger relationships between the advanced therapies industry in the UK and JapanChallenge Theme R&D spotlight: CGT Catapult HEK cell line developed to optimise rAAV vector productionRegulatory Round-up - April 2025INmune Bio partners with Cell and Gene Therapy Catapult to scale up CORDStrom™ manufacturing for commercial readinessRegulatory Round-up - March 2025Regulatory Round-up - February 2025Network established to identify opportunities for regulation to support innovation within advanced therapiesRegulatory Round-up - January 202570% increase in Phase I advanced therapy clinical trials in the UK in 2024Regulatory Round-up - December 2024Cell and Gene Therapy Catapult and UCL Researcher-in-Residence to develop a digital twin of CAR-T manufacturing
